Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma

Angiogenesis is a crucial process in the growth, development, and metastasis of many tumor types, including Non-Hodgkin’s lymphoma (NHL) and Multiple Myeloma (MM). Vascular endothelial growth factor (VEGF) overexpression is known to be associated with poor prognosis in both pathologies, representing...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Camacho Damata, Ximena (author)
Andere auteurs: Perroni, Carolina (author), Carneiro, C G (author), Junqueira, M S (author), Machado, C L (author), Faria, Daniele (author), García Melián, María Fernanda (author), Fernández, M (author), Buchpiguel, Carlos (author), Cerecetto, Hugo (author), Chammas, R. (author), Riva, Eloisa (author), Cabral González, Pablo (author), Gambini, Juan Pablo (author)
Formaat: article
Taal:Engels
Gepubliceerd in: 2022
Onderwerpen:
Online toegang:https://hdl.handle.net/20.500.12008/43413
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
_version_ 1868890020428906496
author Camacho Damata, Ximena
author2 Perroni, Carolina
Carneiro, C G
Junqueira, M S
Machado, C L
Faria, Daniele
García Melián, María Fernanda
Fernández, M
Buchpiguel, Carlos
Cerecetto, Hugo
Chammas, R.
Riva, Eloisa
Cabral González, Pablo
Gambini, Juan Pablo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Buchpiguel, Carlos
Cabral González, Pablo
Camacho Damata, Ximena
Carneiro, C G
Cerecetto, Hugo
Chammas, R.
Faria, Daniele
Fernández, M
Gambini, Juan Pablo
García Melián, María Fernanda
Junqueira, M S
Machado, C L
Perroni, Carolina
Riva, Eloisa
author_facet Camacho Damata, Ximena
Perroni, Carolina
Carneiro, C G
Junqueira, M S
Machado, C L
Faria, Daniele
García Melián, María Fernanda
Fernández, M
Buchpiguel, Carlos
Cerecetto, Hugo
Chammas, R.
Riva, Eloisa
Cabral González, Pablo
Gambini, Juan Pablo
author_role author
collection COLIBRI
dc.contributor.none.fl_str_mv Camacho Damata Ximena, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.
Perroni Carolina, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.
Carneiro C G
Junqueira M S
Machado C L
Faria Daniele
García Melián María Fernanda, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.
Fernández M, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.
Buchpiguel Carlos
Cerecetto Hugo, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.
Chammas R.
Riva Eloisa, Universidad de la República (Uruguay). Facultad de Medicina.
Cabral González Pablo, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.
Gambini Juan Pablo, Universidad de la República (Uruguay). Facultad de Medicina.
dc.creator.none.fl_str_mv Camacho Damata, Ximena
Perroni, Carolina
Carneiro, C G
Junqueira, M S
Machado, C L
Faria, Daniele
García Melián, María Fernanda
Fernández, M
Buchpiguel, Carlos
Cerecetto, Hugo
Chammas, R.
Riva, Eloisa
Cabral González, Pablo
Gambini, Juan Pablo
dc.date.none.fl_str_mv 2022
2024-04-11T12:34:04Z
2024-04-11T12:34:04Z
dc.format.none.fl_str_mv 10 h.
application/pdf
dc.identifier.none.fl_str_mv Camacho Damata, X, Perroni, C, Carneiro, C [y otros autores]. "Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma". Journal of Molecular Biology and Molecular Imaging. [en línea] 2022, 7(1): 1033. 10 h.
2471-0237
https://hdl.handle.net/20.500.12008/43413
dc.language.none.fl_str_mv en
eng
dc.publisher.none.fl_str_mv Austin Publishing Group
dc.relation.none.fl_str_mv Journal of Molecular Biology and Molecular Imaging, 2022, 7(1): 1033.
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
Licencia Creative Commons Atribución (CC - By 4.0)
dc.source.none.fl_str_mv reponame:COLIBRI
instname:Universidad de la República
instacron:Universidad de la República
dc.subject.none.fl_str_mv Bevacizumab
Molecular Imaging
VEGF
Multiple Myeloma
Non-Hodgkin Lymphoma
99mTechnetium- or Cy7-lableled Bevacizumab
dc.title.none.fl_str_mv Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
dc.type.none.fl_str_mv Artículo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
description Angiogenesis is a crucial process in the growth, development, and metastasis of many tumor types, including Non-Hodgkin’s lymphoma (NHL) and Multiple Myeloma (MM). Vascular endothelial growth factor (VEGF) overexpression is known to be associated with poor prognosis in both pathologies, representing a rational target for anti-angiogenic therapy in NHL and MM. The monoclonal antibody Bevacizumab binds to VEGF with high affinity and blocks its action. We aim to evaluate Bevacizumab as a potential radioactive and fluorescence agent for imaging VEGF expression in MM and NHL. Flow cytometry analysis revealed VEGF expression in MM and NHL cell lines is mainly intracellularly. Biodistribution and Single-photon emission computed tomography/computed tomography (SPECT/CT) studies of 99mTc-HYNICBevacizumab showed a slow blood clearance and supradiaphragmatic, head, axial and appendicular skeleton can be evaluated without much interference. Tumor-to-muscle ratio increased with time and is similar to the ones reported with other 99mTc radiolabeled antibodies. Cy7-Bevacizumab fluorescent imaging allowed MM and NHL tumor visualization with greater spatial resolution than SPECT/CT. We successfully synthesized 99mTc and Cy7-labeled anti-VEGF mAb (Bevacizumab) to be used to target VEGF expression in vivo in MM and LNH. Our encouraging results, although working with 99mTc, highlight the importance of radioinmuno-oncology as a potential tool to fight these diseases. Optical imaging of these tracers would enhance tumor sampling and guide surgical removal.
eu_rights_str_mv openAccess
format article
id anni_41dddcbd5fb8da952481ea4145fefc67
identifier_str_mv Camacho Damata, X, Perroni, C, Carneiro, C [y otros autores]. "Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma". Journal of Molecular Biology and Molecular Imaging. [en línea] 2022, 7(1): 1033. 10 h.
2471-0237
instacron_str Universidad de la República
institution Universidad de la República
instname_str Universidad de la República
language eng
language_invalid_str_mv en
network_acronym_str anni
network_name_str oai-lr-anni
oai_identifier_str oai:colibri.udelar.edu.uy:20.500.12008/43413
publishDate 2022
publishDateSort 2022
publisher.none.fl_str_mv Austin Publishing Group
reponame_str COLIBRI
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv Licencia Creative Commons Atribución (CC - By 4.0)
spelling Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin LymphomaCamacho Damata, XimenaPerroni, CarolinaCarneiro, C GJunqueira, M SMachado, C LFaria, DanieleGarcía Melián, María FernandaFernández, MBuchpiguel, CarlosCerecetto, HugoChammas, R.Riva, EloisaCabral González, PabloGambini, Juan PabloBevacizumabMolecular ImagingVEGFMultiple MyelomaNon-Hodgkin Lymphoma99mTechnetium- or Cy7-lableled BevacizumabAngiogenesis is a crucial process in the growth, development, and metastasis of many tumor types, including Non-Hodgkin’s lymphoma (NHL) and Multiple Myeloma (MM). Vascular endothelial growth factor (VEGF) overexpression is known to be associated with poor prognosis in both pathologies, representing a rational target for anti-angiogenic therapy in NHL and MM. The monoclonal antibody Bevacizumab binds to VEGF with high affinity and blocks its action. We aim to evaluate Bevacizumab as a potential radioactive and fluorescence agent for imaging VEGF expression in MM and NHL. Flow cytometry analysis revealed VEGF expression in MM and NHL cell lines is mainly intracellularly. Biodistribution and Single-photon emission computed tomography/computed tomography (SPECT/CT) studies of 99mTc-HYNICBevacizumab showed a slow blood clearance and supradiaphragmatic, head, axial and appendicular skeleton can be evaluated without much interference. Tumor-to-muscle ratio increased with time and is similar to the ones reported with other 99mTc radiolabeled antibodies. Cy7-Bevacizumab fluorescent imaging allowed MM and NHL tumor visualization with greater spatial resolution than SPECT/CT. We successfully synthesized 99mTc and Cy7-labeled anti-VEGF mAb (Bevacizumab) to be used to target VEGF expression in vivo in MM and LNH. Our encouraging results, although working with 99mTc, highlight the importance of radioinmuno-oncology as a potential tool to fight these diseases. Optical imaging of these tracers would enhance tumor sampling and guide surgical removal.ANII: POS_NAC_2015_1_109490CSIC: 240600-000148-18Austin Publishing GroupCamacho Damata Ximena, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.Perroni Carolina, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.Carneiro C GJunqueira M SMachado C LFaria DanieleGarcía Melián María Fernanda, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.Fernández M, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.Buchpiguel CarlosCerecetto Hugo, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.Chammas R.Riva Eloisa, Universidad de la República (Uruguay). Facultad de Medicina.Cabral González Pablo, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares.Gambini Juan Pablo, Universidad de la República (Uruguay). Facultad de Medicina.2024-04-11T12:34:04Z2024-04-11T12:34:04Z2022Artículoinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion10 h.application/pdfCamacho Damata, X, Perroni, C, Carneiro, C [y otros autores]. "Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma". Journal of Molecular Biology and Molecular Imaging. [en línea] 2022, 7(1): 1033. 10 h.2471-0237https://hdl.handle.net/20.500.12008/43413reponame:COLIBRIinstname:Universidad de la Repúblicainstacron:Universidad de la RepúblicaenengJournal of Molecular Biology and Molecular Imaging, 2022, 7(1): 1033.Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)info:eu-repo/semantics/openAccessLicencia Creative Commons Atribución (CC - By 4.0)oai:colibri.udelar.edu.uy:20.500.12008/434132026-04-14T10:10:38Z
spellingShingle Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
Camacho Damata, Ximena
Bevacizumab
Molecular Imaging
VEGF
Multiple Myeloma
Non-Hodgkin Lymphoma
99mTechnetium- or Cy7-lableled Bevacizumab
status_str publishedVersion
title Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
title_full Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
title_fullStr Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
title_full_unstemmed Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
title_short Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
title_sort Molecular imaging of VEGF expression in multiple myeloma and non-Hodgkin Lymphoma
topic Bevacizumab
Molecular Imaging
VEGF
Multiple Myeloma
Non-Hodgkin Lymphoma
99mTechnetium- or Cy7-lableled Bevacizumab
url https://hdl.handle.net/20.500.12008/43413